Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: gbull who wrote (9319)	5/22/1998 9:12:00 AM
From: Ron Luhmann	Respond to of 14328

shareholder meeting Monday...I've heard... I'm anxious to hear about Dr. Branson and the CDC trials...rumors of an acquisition in TRIBY's future...without dilution...bring that EPS up where it belongs!.... OK ..... Gimmea a "T"...Gimmean...."RIBY"........ ........GOOOO TRIBY!...Rah! :-) Ron

To: gbull who wrote (9319)	5/22/1998 2:12:00 PM
From: Scott H. Davis	Respond to of 14328

Reflections on EPS: A change for the better from my perspective - the DLJ analyst covering TRIBY has made a huge change to his EPS estimates for this and next year. There were .20 and .30 for FY 98 and 99, and now are .10 and .22. I see that as good news, since the probable end of year EPS downside surprise has now shrunk from 110% to 10% based on TRIBY management projections. The fact that he has reviewed things and still sees over 100% EPS growth for next year is still very bullish. Before anybody gets too estatic about next year, remember that the guy hasbeen way to high twice now. (last year he called for .15 vs .06 actual). Let's hope he did his homework and is closer to the mark now. BTW, for some additional thoughts on EPS growth and FA valuations mixed with projected growth, youmay want to consider the following link. Scott (no longer furious) exchange2000.com